Select Publications and Presentations
Please contact medinfo@encoded.com for a copy of any of the medical or scientific conference presentations listed below.
Behavior, social-emotional, and sleep difficulties in young children with SCN1A+ Dravet Syndrome Participating in the ENVISION study, an international, prospective natural history study
American Epilepsy Society (AES) 2022 Annual Meeting
December 2022
The ENVISION Study, an international, prospective natural history study in young children with SCN1A+ Dravet syndrome, 18-month follow-up
American Epilepsy Society (AES) 2022 Annual Meeting
December 2022
Optimized human regulatory sequences achieve targeted expression in brain and decreased off-target liver and dorsal root ganglion expression
European Society of Gene and Cell Therapy (ESGCT) 29th Congress
October 2022
The ENVISION Study, an international, prospective natural history study in young children with SCN1A+ Dravet syndrome
International League Against Epilepsy (ILAE) – 14th European Epilepsy Congress
July 2022
American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting
May 2022
The ENVISION Study, an International, Prospective Natural History Study in Young Children with SCN1A+ Dravet Syndrome
14th European Paediatric Neurology Society Congress
April 2022
Human Gene Therapy
April 2022
Epilepsy and Behavior
April 2022
ENVISION: An International, Prospective Natural History Study in Young Children with SCN1A+ Dravet Syndrome
American Epilepsy Society (AES) 2021 Annual Meeting
December 2021
Molecular Diagnostic and Phenotypic Findings in Individuals With SCN1A-Related Disease Identified Through a Sponsored, No-Charge Epilepsy Genetic Testing Program
American Epilepsy Society (AES) 2021 Annual Meeting
December 2021
A Patient-Oriented Approach to Integrating Families’ Experiences in Clinical Trials Design and Clinical Care for Dravet Syndrome
American Epilepsy Society (AES) 2021 Annual Meeting
December 2021
DRAVET ENGAGE. Parent Caregivers of Children with Dravet Syndrome: Perspectives, Needs, and Opportunities for Clinical Research
International League Against Epilepsy (ILAE) – 34th International Epilepsy Congress
August 2021
The Clinical, Economic, and Humanistic Burden of Dravet Syndrome — A Systematic Literature Review
International League Against Epilepsy (ILAE) – 34th International Epilepsy Congress
August 2021
Epilepsy and Behavior
July 2021
ETX101, a GABAergic Interneuron Selective AAV-mediated Gene Therapy for Treatment of SCN1A+ Dravet Syndrome: Biodistribution and Safety in Non-human Primates
American Epilepsy Society (AES) 2020 Annual Meeting
December 2020
Reducing the time to diagnosis and increasing the detection of individuals with SCN1A-related disease through a sponsored epilepsy genetic testing program
American Epilepsy Society (AES) 2020 Annual Meeting
December 2020
Fundación Síndrome de Dravet Webinar
December 2020
From Gene Replacement to Gene Regulation: Developing a Disease-Modifying AAV Gene Therapy Vector for SCN1A-Positive (SCN1A+) Dravet Syndrome
American Epilepsy Society (AES) 2019 Annual Meeting
December 2019
Proposed Design for a Natural History Study of SCN1A-Positive (SCN1A+) Dravet Syndrome
American Epilepsy Society (AES) 2019 Annual Meeting
December 2019
Efficient Delivery of Clinically-Validated Adeno-Associated Viral (AAV) Vectors to the Central Nervous System: A Systematic Evaluation of Multiple Routes of Administration and Viral Serotypes in Cynomolgus Macaques
American Society of Gene and Cell Therapy (ASGCT) 22nd Annual Meeting
May 2019
A GABA-Selective AAV Vector-Based Approach to Up-Regulate Endogenous Scn1a Expression Reverses Key Phenotypes in a Mouse Model of Dravet Syndrome
American Society of Gene and Cell Therapy (ASGCT) 22nd Annual Meeting
May 2019